Search Results 691-700 of 24184 for In situ
Drugs used in chemotherapy, such as cisplatin, work in different ways to stop ... in situ carcinoma of the cervix). Patients are excluded if they have ...
Subject has/had cancer requiring treatment currently or in the past 3 years (except primary nonmelanoma skin cancer, carcinoma in situ or cancers that have ...
... in Subjects with Chronic Lymphocytic Leukemia (CLL) ... Progressive lymphocytosis in the absence of infection, with an increase in ... situ carcinomas, superficial ...
Other active malignancy ≤ 3 years prior to randomization; EXCEPTIONS: Non melanotic skin cancer or carcinoma-in-situ of the cervix * Note: If there is a ...
... in situ with or without Ta/T1 disease. Establishment of Preclinical Models from Patients with Gynecological Malignancies. Rochester, Minn., Scottsdale ...
To explore the relationship between dupilumab concentration and responses in adult and adolescent patients with EoE, using descriptive analyses. To evaluate the ...
... in-situ, or ≤ 2 squamous cell carcinomas of the skin 6. History of clinically significant (as determined by the Investigator) non-PAH related cardiac ...
However, adequately treated basal cell or squamous cell skin cancer or non-invasive superficial bladder cancer or carcinoma in situ of the bladder, breast ...
Exceptions include basal cell carcinoma of the skin, carcinoma in situ of the cervix or other noninvasive or indolent malignancy that has previously undergone ...
Patients with non-melanoma skin cancer, carcinoma in situ (including superficial bladder cancer), cervical intraepithelial neoplasia and organ-confined ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.